Common anti-seizure drug prevents Alzheimer’s plaques from forming
February 11, 2026
While other drugs clear existing plaques, levetiracetam prevents production of toxic amyloid beta peptides
While other drugs clear existing plaques, levetiracetam prevents production of toxic amyloid beta peptides
Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
BVI announced the first successful U.S. implantations of the FDA-approved FineVision HP hydrophobic trifocal intraocular lens (IOL).
BURLINGTON, N.C., Feb. 11, 2026 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide availability of the Elecsys® pTau-181 test, the first and only blood test cleared by the U.S. Food and Drug Administration (FDA) to aid in the initial assessment of Alzheimer’s disease in the primary care setting. This launch further expands Labcorp’s comprehensive portfolio of Alzheimer’s disease blood tests, offering clinicians solutions across both primary and specialty care settings.
A wearable biosensor developed by Washington State University researchers could improve wireless glucose monitoring for people with diabetes, making it more cost-effective, accurate, and less invasive than current models.
Researchers have developed a new artificial intelligence-based approach for detecting fatty deposits inside coronary arteries using optical coherence tomography (OCT) images.
“By using a simple and inexpensive technique that pathologists already use every day, it is now possible to make a better risk assessment, even in countries where advanced technologies are not available.”
Rresearchers reared mice fitted with miniature goggles that biased their perception of the visual world. One group of animals only saw edges oriented at a certain angle, while the other saw edges oriented at a different angle.
New research from McMaster University suggests that disruptions in a person’s sleep and daily activity routine, as detected through a simple wrist-worn device, can signal when there is increased risk of relapsing into major depression.
National Institutes of Health (NIH) researchers have developed a digital replica of crucial eye cells, providing a new tool for studying how the cells organize themselves when they are healthy and affected by diseases.